Company Quick10K Filing
Innovus Pharmaceuticals
10-Q 2019-09-30 Filed 2019-11-14
10-Q 2019-06-30 Filed 2019-08-13
10-Q 2019-03-31 Filed 2019-05-15
S-1 2019-01-14 Public Filing
10-K 2018-12-31 Filed 2019-04-01
10-Q 2018-09-30 Filed 2018-11-14
10-Q 2018-06-30 Filed 2018-08-14
10-Q 2018-03-31 Filed 2018-05-14
10-K 2017-12-31 Filed 2018-04-02
10-Q 2017-09-30 Filed 2017-11-14
10-Q 2017-06-30 Filed 2017-08-14
10-Q 2017-03-31 Filed 2017-05-15
10-K 2016-12-31 Filed 2017-03-09
10-Q 2016-09-30 Filed 2016-11-14
10-Q 2016-06-30 Filed 2016-08-15
10-Q 2016-03-31 Filed 2016-05-16
10-K 2015-12-31 Filed 2016-03-30
10-Q 2015-09-30 Filed 2015-11-16
10-Q 2015-06-30 Filed 2015-08-14
10-Q 2015-03-31 Filed 2015-05-15
10-K 2014-12-31 Filed 2015-03-31
10-Q 2014-09-30 Filed 2014-11-14
10-Q 2014-06-30 Filed 2014-08-14
10-Q 2014-03-31 Filed 2014-05-14
10-K 2013-12-31 Filed 2014-03-28
10-Q 2013-09-30 Filed 2013-11-14
10-Q 2013-06-30 Filed 2013-08-13
10-Q 2013-03-31 Filed 2013-05-10
10-K 2012-12-31 Filed 2013-03-19
10-Q 2012-06-30 Filed 2012-08-06
10-Q 2012-03-31 Filed 2012-05-10
10-K 2011-12-31 Filed 2012-03-30
10-Q 2011-09-30 Filed 2011-10-19
10-Q 2011-06-30 Filed 2011-08-15
10-Q 2011-03-31 Filed 2011-05-13
10-K 2010-12-31 Filed 2011-03-25
10-Q 2010-09-30 Filed 2010-11-03
10-Q 2010-06-30 Filed 2010-08-10
10-Q 2010-03-31 Filed 2010-05-12
10-K 2009-12-31 Filed 2010-05-05
8-K 2020-02-14
8-K 2020-02-13
8-K 2019-09-12
8-K 2019-07-23
8-K 2019-07-22
8-K 2019-06-30
8-K 2019-06-19
8-K 2019-06-05
8-K 2019-05-28
8-K 2019-05-28
8-K 2019-04-18
8-K 2019-04-11
8-K 2019-04-01
8-K 2019-03-31
8-K 2019-03-14
8-K 2019-02-22
8-K 2019-01-03
8-K 2018-12-30
8-K 2018-11-14
8-K 2018-08-31
8-K 2018-08-14
8-K 2018-08-10
8-K 2018-07-17
8-K 2018-05-29
8-K 2018-05-29
8-K 2018-05-14
8-K 2018-04-19
8-K 2018-04-02
8-K 2018-04-02
8-K 2018-01-20
8-K 2018-01-08

Innovus Pharmaceuticals Financials

INNV Metrics, Comps, Filings

Quarterly | Annual

Valuation ($MM)

Market Cap, Enterprise Value

Balance Sheet ($MM)

Assets, Equity

Income Statement ($MM Quarterly)

Revenue, G Profit, Net Income

Cash Flow ($MM Quarterly)

Ops, Inv, Fin

Comps ($'000 TTM) Market Cap Gross Margin EV/EBITDA Ret on Assets Assets Liabilities Revenue G Profit Net Income EBITDA EV
BAB (BABB) 5,811 0% 10.7 9% 4,216 1,365 2,043 0 398 409 4,382
Peerlogix (LOGX) 6,143 0% -2.5 -18,131% 30 8,043 35 0 -5,364 -3,305 8,246
Pacific Office Properties Trust (PCFO) 6,101 7.0 4% 181,597 344,087 0 0 8,115 36,200 254,147
VGrab (VGRBF) 6,037 -17.1 -1,121% 32 1,286 0 0 -359 -352 6,021
Remedent (REMI) 5,999 70% 2.8 26% 7,927 2,787 1,375 966 2,038 2,140 5,914
Enerteck (ETCK) 5,821 74% -5.9 -322% 291 8,494 38 28 -938 -984 5,809
Innovus Pharmaceuticals (INNV) 5,796 65% -2.1 -63% 9,514 11,510 17,966 11,617 -5,984 -3,875 8,027
Community Savings Bancorp (CCSB) 5,722 79% -103.5 -0% 51,189 43,559 75 59 -185 -29 3,000
First Hartford (FHRT) 5,674 26% -0.2 2% 248,671 244,456 79,815 21,110 6,017 18,447 -3,166
National American University Holdings (NAUH) 5,670 0% 0.1 -66% 38,045 46,203 52,110 0 -25,051 -22,125 -3,290
Wall Street Media (WSCO) 5,654 0% 242.1 260% 9 104 140 0 23 23 5,645
Exco Resources (XCO) 5,638 0% 0.6 -18% 1,032,693 2,059,189 303,562 0 -182,697 -90,270 -56,952
Imine (JRVS) 5,585 -4.0 -72,547% 2 590 0 0 -1,527 -1,527 6,083
Interlink Plus (ITRK) 5,580 0% -169.0 -786% 6 250 44 0 -50 -33 5,576
REGI (RGUS) 5,528 0% -2.6 -467% 457 2,939 45 0 -2,135 -2,100 5,557
THt Heat Transfer Technology (THTI) 5,522 80% 0.1 8% 108,600 49,264 32,700 26,064 9,031 10,780 1,517
Amedica (AMDA) 5,471 35% 0.1 -97% 14,397 6,307 6,764 2,378 -14,003 -13,648 -1,322
Biorestorative Therapies (BRTX) 5,455 0% -0.4 -898% 1,458 13,887 98 0 -13,097 -12,936 5,514
Laredo Oil (LRDC) 5,451 2% -45.9 -41% 357 2,059 8,480 196 -146 -113 5,162
Gridiron Bionutrients (GMVP) 5,358 -44% -5.9 -275% 331 252 83 -37 -913 -910 5,344

Balance Sheet ($'000)2011-09-302011-12-312012-03-312012-09-302013-03-312013-06-302013-09-302013-12-312014-03-312014-06-302014-09-302014-12-312015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302018-12-312019-03-312019-06-302019-09-30
Cash25603311313826331144577561615056332,3001,4558302,3751,8251,3151,5654,9241,6147031,2481,9471,574955
Accounts Receivable075217211153428192813868834522313415212868195287356282130319117
Inventory1782082012302662732913112542722223976005375866401,7261,6492,2292,1982,3702,1301,8531,742
PP&E7958506355686053654383432654293231699203179206937229227216
Assets2560331133943762,1132,1651,9912,2702,0816,8856,6476,7836,4456,7388,0019,0608,2279,2628,4147,6779,03112,3939,9359,50310,12711,36910,8379,514
Accounts Payable6472,3061,845
Long-Term Debt250350133706296291,590060557141289899592479403,2182,4293,1714,0812,9663,1343,186
Liabilities1682632265737901,0162,1721,7212,1282,2522,5075,7656,2126,4736,8917,9988,1799,0677,1336,2146,3706,4558,1289,6888,7658,64510,01810,30810,79111,510
Stockholders' Equity-62-143-203-193-460-396-640148444-13719-4261,121435310-446-1,260-178-81,0943,0482,0451,2229032,7051,1718581091,06146-1,996
Income Statement ($'000)2011-09-302011-12-312012-03-312012-09-302013-03-312013-06-302013-09-302013-12-312014-03-312014-06-302014-09-302014-12-312015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302018-12-312019-03-312019-06-302019-09-30
Revenue000061662804433071971831801762251,0201,8821,6912,1772,3342,2212,3804,5459,6367,3805,3636,8485,755
Cost of Revenue056216641021,5371,7782,3562,215
Gross Profit011063119775,8433,5854,4923,540
R&D0000662756541915000044430315912112559569186
SG&A7285621434946487141,2861,6449941,0931,4489027318291,3231,1953,7513,2223,3922,7382,9482,9514,9989,4987,2875,0305,5825,152
Tax0000002300000
Net Income-7-2,239-60-78-337-2,117-734-768-1,439-1,086-1,127-1,175-1,502-864-859-978-1,555-4,360-4,426-3,360-2,546746-1,329-1,496-1,829-1,840-2,450-1,989-1,759-2,236
Cash Flow ($'000)2011-09-302011-12-312012-03-312012-09-302013-03-312013-06-302013-09-302013-12-312014-03-312014-06-302014-09-302014-12-312015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302018-12-312019-03-312019-06-302019-09-30
Cash Operating-194-53-120-185-215-125-248-287-36054-92-37-658-246-105362-996-1,045-496-474-577-815-663-2,798-2,127-602-754-514
Cash Investing00-44-62-10-3-00-70-150-16-2-6-2-47-14813-61-343-16-5
Cash Financing217882142101081283292173229150079115289-1962,4024362,043-71701,0824,170-5251,2761,644397-100